UBS O'Connor’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3M | Buy |
42,998
+36,387
| +550% | +$2.54M | 0.15% | 101 |
|
|
2025
Q1 | $486K | Sell |
6,611
-54,836
| -89% | -$4.03M | 0.01% | 205 |
|
|
2024
Q4 | $4.03M | Buy |
+61,447
| New | +$4.03M | 0.11% | 97 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 415 |
|
|
2024
Q2 | – | Sell |
-54,284
| Closed | -$3.68M | – | 441 |
|
|
2024
Q1 | $3.68M | Buy |
54,284
+22,217
| +69% | +$1.51M | 0.11% | 108 |
|
|
2023
Q4 | $2.16M | Sell |
32,067
-17,475
| -35% | -$1.18M | 0.07% | 160 |
|
|
2023
Q3 | $3.35M | Buy |
49,542
+16,000
| +48% | +$1.08M | 0.06% | 168 |
|
|
2023
Q2 | $2.4M | Sell |
33,542
-11,658
| -26% | -$834K | 0.05% | 246 |
|
|
2023
Q1 | $3.14M | Buy |
+45,200
| New | +$3.14M | 0.07% | 198 |
|
|
2022
Q4 | – | Sell |
-96,430
| Closed | -$5.29M | – | 47 |
|
|
2022
Q3 | $5.29M | Buy |
96,430
+15,000
| +18% | +$823K | 0.06% | 200 |
|
|
2022
Q2 | $5.38M | Buy |
+81,430
| New | +$5.38M | 0.06% | 212 |
|
|
2015
Q1 | – | Sell |
-176,796
| Closed | -$6.22M | – | 689 |
|
|
2014
Q4 | $6.22M | Hold |
176,796
| – | – | 0.11% | 182 |
|
|
2014
Q3 | $6.32M | Hold |
176,796
| – | – | 0.11% | 194 |
|
|
2014
Q2 | $6.57M | Buy |
+176,796
| New | +$6.57M | 0.04% | 177 |
|